S&P 500

5.930,85

1,09%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Alkido Pharma Inc (AIKI)
Alkido Pharma Inc (AIKI) Notícias

AIKI

Alkido Pharma (AIKI)

Alkido Pharma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AIKI

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/06/2023	09:17	PR Newswire (US)	Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"	NASDAQ:AIKI	Alkido Pharma Inc
15/06/2023	17:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIKI	Alkido Pharma Inc
06/06/2023	17:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIKI	Alkido Pharma Inc
11/05/2023	07:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AIKI	Alkido Pharma Inc
03/04/2023	10:03	PR Newswire (US)	Dominari Holdings Appoints George Way Chief Financial Officer	NASDAQ:AIKI	Alkido Pharma Inc
24/02/2023	11:00	PR Newswire (US)	Dominari Holdings Provides Update on Share Repurchase Program	NASDAQ:AIKI	Alkido Pharma Inc
06/01/2023	18:42	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AIKI	Alkido Pharma Inc
22/12/2022	10:00	PR Newswire (US)	AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)	NASDAQ:AIKI	Alkido Pharma Inc
28/11/2022	11:00	PR Newswire (US)	AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes	NASDAQ:AIKI	Alkido Pharma Inc
11/11/2022	11:55	TipRanks	AIkido Pharma (AIKI) Gets a Buy from H.C. Wainwright	NASDAQ:AIKI	Alkido Pharma Inc
21/10/2022	17:02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:AIKI	Alkido Pharma Inc
21/10/2022	17:01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AIKI	Alkido Pharma Inc
06/10/2022	10:10	PR Newswire (US)	AIkido Share Repurchase Continues	NASDAQ:AIKI	Alkido Pharma Inc
05/10/2022	10:00	PR Newswire (US)	AIkido Purchases More Shares	NASDAQ:AIKI	Alkido Pharma Inc
04/10/2022	10:00	PR Newswire (US)	Share Repurchase Program Continues	NASDAQ:AIKI	Alkido Pharma Inc
03/10/2022	10:00	PR Newswire (US)	AIkido Pharma Continues Share Repurchase Program	NASDAQ:AIKI	Alkido Pharma Inc
30/09/2022	10:00	PR Newswire (US)	AIkido Pharma Provides Update on Share Repurchase Program	NASDAQ:AIKI	Alkido Pharma Inc
09/09/2022	19:25	PR Newswire (US)	Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer	NASDAQ:AIKI	Alkido Pharma Inc
07/09/2022	18:01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AIKI	Alkido Pharma Inc
22/08/2022	07:15	TipRanks	H.C. Wainwright Remains a Buy on AIkido Pharma (AIKI)	NASDAQ:AIKI	Alkido Pharma Inc
10/08/2022	09:30	PR Newswire (US)	AIkido Pharma Confirms Receipt of Unsolicited Offer	NASDAQ:AIKI	Alkido Pharma Inc
09/08/2022	09:30	GlobeNewswire Inc.	Investor Makes Proposal to Acquire AIkido Pharma for $8.00 Per Share in Cash	NASDAQ:AIKI	Alkido Pharma Inc
21/07/2022	10:30	PR Newswire (US)	AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary	NASDAQ:AIKI	Alkido Pharma Inc
28/06/2022	10:00	PR Newswire (US)	AIkido Pharma Inc. Regains Compliance with NASDAQ Listing Requirements	NASDAQ:AIKI	Alkido Pharma Inc
24/06/2022	10:00	PR Newswire (US)	AIkido Inc. Announces the Formation of a New Financial Services Subsidiary	NASDAQ:AIKI	Alkido Pharma Inc
21/06/2022	17:30	GlobeNewswire Inc.	Significant Investor in AIkido Pharma Urges Board to Commit to Sell Assets and Return Capital to Stockholders	NASDAQ:AIKI	Alkido Pharma Inc
10/06/2022	17:15	PR Newswire (US)	AIkido Pharma Inc. Appoints New Director, Soo Yu	NASDAQ:AIKI	Alkido Pharma Inc
07/06/2022	17:30	GlobeNewswire Inc.	Significant Investor in AIkido Pharma Issues Open Letter to Board of Directors	NASDAQ:AIKI	Alkido Pharma Inc
07/06/2022	07:26	TipRanks	H.C. Wainwright Thinks AIkido Pharma’s Stock is Going to Recover	NASDAQ:AIKI	Alkido Pharma Inc
03/06/2022	17:30	PR Newswire (US)	AIkido Announces Reverse Stock Split	NASDAQ:AIKI	Alkido Pharma Inc